Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases

Award Notice Posted

Solicitation number
7529
Agency
Awarded
to Dynport Vaccine Company LLC
Set-aside
No set-aside

Opportunity facts

Contract number
75N93025D00025 Federal IDV award
NAICS code
Not on record
PSC
Not on record
Place of performance
Maryland 21702, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, awarded Contract 75N93025D00025 to DynPort Vaccine Company LLC for Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases. This Indefinite Delivery/Indefinite Quantity (IDIQ) contract was awarded on September 30, 2026, with a guaranteed minimum of $10,000 and a maximum ordering limit of $136,578,701. The contract will provide critical evaluation and testing services to support vaccine and biologic development and assessment for infectious disease applications, with the potential to deliver substantial value across the government's vaccine development and safety portfolio over the contract term.

Notice text

- IDIQ Guaranteed Minimum: $10,000 - Amount Obligated on Base IDIQ Contract Award

- Maximum Ordering Limit: $136,578,701

Awarded contract 75N93025D00025 to DYNPORT VACCINE COMPANY LLC for 10000.00 on 2026-09-30.

Notice history

5 of 13 notices listed here. See the rest on GovTribe.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity